Peter Marks, former director of the center for biologics evaluation and research at the U.S. Food and Drug Administration (FDA), speaks during a Senate Health, Education, Labor, and Pensions Committee hearing in Washington, D.C., U.S., on Tuesday, May 11, 2021.
Jim Lo Scalzo/EPA/Bloomberg via Getty Images
